Pristop sintezne biologije za načrtovanje kandidata za cepivo proti delta različici SARSCoV2 je razkril motnjo favoriziranega para kodonov kot boljšo strategijo pred uporabo redkih kodonov: Difference between revisions

From Wiki FKKT
Jump to navigationJump to search
No edit summary
No edit summary
Line 1: Line 1:
''Povzeto po članku: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967482/.Gurjar, P., Karuvantevida, N., Rzhepakovsky, I. V., Khan, A. A., & Khandia, R. (2023). A synthetic biology approach for vaccine candidate design against delta strain of sars-cov-2 revealed disruption of favored codon pair as a better strategy over using rare codons. Vaccines, 11(2), 487. ]''
''Povzeto po članku: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9967482/. Gurjar, P., Karuvantevida, N., Rzhepakovsky, I. V., Khan, A. A., & Khandia, R. (2023). A synthetic biology approach for vaccine candidate design against delta strain of sars-cov-2 revealed disruption of favored codon pair as a better strategy over using rare codons. Vaccines, 11(2), 487. ]''

Revision as of 17:31, 7 May 2023

Povzeto po članku: Gurjar, P., Karuvantevida, N., Rzhepakovsky, I. V., Khan, A. A., & Khandia, R. (2023). A synthetic biology approach for vaccine candidate design against delta strain of sars-cov-2 revealed disruption of favored codon pair as a better strategy over using rare codons. Vaccines, 11(2), 487.

Retrieved from "https://wiki.fkkt.uni-lj.si/index.php?title=Pristop_sintezne_biologije_za_načrtovanje_kandidata_za_cepivo_proti_delta_različici_SARSCoV2_je_razkril_motnjo_favoriziranega_para_kodonov_kot_boljšo_strategijo_pred_uporabo_redkih_kodonov&oldid=21895"